Nanoparticles in Peritoneal Carcinomatosis

Abstract

The management of peritoneal metastasis remains controversial. The logo regional treatments are Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and recently the Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). Both methods were improved the survival and quality of life in precisions selected patients. On the other hand major progress has been made through nanoparticles. In this short review presented the use of nanoparticles a novel tool increase drug delivery and penetration and may be more effective in patients with peritoneal metastasis.